Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael S. Huie
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase Iiib Study of Lenalidomide Plus Rituximab Followed by Maintenance in Relapsed or Refractory Nhl: Analysis of Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab Maintenance After Nordic Protocol (R-Maxichop/Hd-Arac/Asct) Significantly Prolongs Survival in Young Mantle Cell Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Evolution of Clonal Hematopoiesis in Mantle Cell Lymphoma Patients Before, During, and After Induction Chemotherapy and Autologous Stem Cell Transplantation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab and FAB/LMB 96 Chemotherapy in Children With Stage III/IV B-Cell Non-Hodgkin Lymphoma: A Children’s Oncology Group Report
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Prospective Clinical Study of R-CMD Therapy for Indolent B Cell Lymphoma and Mantle Cell Lymphoma From the Hokuriku Hematology Oncology Study Group
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology